JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2017 • Cormorant Asset Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 14, 2017, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • December 28th, 2020 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of December 28, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 16th, 2023 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of November 16, 2023, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • March 26th, 2021 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of March 26, 2021, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • January 19th, 2021 • Cormorant Asset Management, LP • Services-medical laboratories
This Joint Filing Agreement, dated as of January 19, 2021, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 12th, 2020 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of November 12, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • October 23rd, 2023 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of October 23, 2023, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2017 • Cormorant Asset Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 14, 2017, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 20th, 2020 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of July 20, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2019 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 14, 2019, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • August 15th, 2016 • Cormorant Asset Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of August 15, 2016, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • April 27th, 2020 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of April 27, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • April 25th, 2019 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of April 25, 2019, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 2nd, 2018 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of July 2, 2018, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the "Filers").
JOINT FILING AGREEMENTJoint Filing Agreement • July 8th, 2021 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of July 8, 2021, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 2nd, 2021 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of July 2, 2021, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 30th, 2021 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of July 30, 2021, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 7th, 2019 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of November 7, 2019, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • October 16th, 2020 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of October 16, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • January 30th, 2017 • Cormorant Asset Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of January 30, 2017, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • December 29th, 2022 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of December 29, 2022, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 7th, 2022 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of July 7, 2022, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • December 16th, 2019 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of December 16, 2019, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • June 17th, 2022 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of June 17, 2022, is by and among Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2024 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 14, 2024, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 2nd, 2018 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of July 2, 2018, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • August 29th, 2022 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of August 29, 2022, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 13th, 2020 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of November 13, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
ContractJoint Filing Agreement • September 11th, 2017 • Cormorant Asset Management, LLC • Pharmaceutical preparations
JOINT FILING AGREEMENTJoint Filing Agreement • September 29th, 2016 • Cormorant Asset Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of September 29, 2016, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 12th, 2021 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of July 12, 2021, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • April 22nd, 2019 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of April 22, 2019, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • April 21st, 2017 • Cormorant Asset Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of April 21, 2017, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 14, 2022, is by and between Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • May 20th, 2019 • Cormorant Asset Management, LP • Blank checks
This Joint Filing Agreement, dated as of May 20, 2019, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
